The MEA parenteral nutrition
market is expected to reach USD 377.1 million by 2025 according to
a new report by Grand View Research, Inc. The MEA parenteral nutrition market
is expected to witness lucrative growth over the forecast period owing to
various parameters such as presence of large pool of malnourished children,
rising premature births, increasing adoption by healthcare settings for
nutrient administration in chronically ill geriatric patients, and rising
prevalence rate of cancer within the region.
Increasing prevalence of chronic
conditions such as cancer unswervingly influences the use of parenteral
nutrition across the globe. Parenteral nutrition helps in the administration of
key vital nutrients that are useful in maintaining strength, energy, and
hydration level in cancer patients, thus, acting a vital impact rendering
driver expected to surge market growth over the forecast period.
Similarly, predominant existence of
malnourished children and premature neonates that require these nutrients, is
expected to further propel the growth. According to statistics published by the
Knoema, a public data platform, the prevalence of the malnutrition in Middle
East and North Africa in 2013 was around 6.04%, however, it has witnessed a
decline over the period of time.
Browse full research report on MEA Parenteral Nutrition Market: https://www.grandviewresearch.com/industry-analysis/mea-parenteral-nutrition-market
Further Key Findings From the Study Suggest:
- Single dose amino acid solutions held a dominant share in
2016. This dominance is governed by the influx of innovative products. In
addition, these innovative formulations are more efficient and cause
lesser adverse effects.
- Intravenous lipid emulsions are anticipated to witness
lucrative growth over the forecast period. Drug delivery through lipid
emulsion is expected to showcase promising results as it results in
minimal adverse effects such as irritation, pain, and thrombophlebitis.
- Bags dominated the Middle East parenteral nutrition market
with more than 67.00% share in 2016. These packaging materials are easy to
handle, transport, and are cost-efficient.
- Vials are used for smaller concentration dose, often in
hospital compounding. Increasing focus on customized treatment is likely
to boost the usage of vials.
- Saudi Arabia held largest share in MEA parenteral nutrition
market in 2016. However, countries such as Kuwait, Oman, Lebanon, and
Jordan are anticipated to gain remunerative share over the forecast period.
- Key market players of the MEA parenteral nutrition industry
are B. Braun Melsungen AG; Baxter; Fresenius Kabi AG; Hospira Inc.; Qatar
Pharma Factory; Pharmaceutical Solutions Industry; Kuwait Saudi
Pharmaceutical Industries Co.; Alfa Laboratories; and Well Pharma.
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/mea-parenteral-nutrition-market/request/rs1
Grand View Research has segmented the MEA parenteral nutrition
market by nutrient type, dosage form, and region:
MEA Parenteral Nutrition Nutrient Type Outlook (Revenue, USD
Million; 2014 - 2025)
- Carbohydrate
- Parenteral
Lipid Emulsions
- Single
Dose Amino Acid Solutions
- Trace
Elements
- Vitamins
and Minerals
MEA Parenteral Nutrition Dosage Form Outlook (Revenue, USD
Million; 2014 - 2025)
- Vials
- Ampoules
- Bottles
- Bags
- Multi
chambered bags
- Other
bags
MEA Parenteral Nutrition Regional Outlook (Revenue, USD Million;
2014 - 2025)
- Saudi
Arabia
- Qatar
- Kuwait
- UAE
- Oman
- Egypt
- Lebanon
- Jordan
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For
more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment